Company / Interest Expense
Twist Bioscience Corp Interest Expense History
FY2017-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$5.0K
FY2023
5-year range
$5.0K / $367.0K
FY2019-FY2023
Trend
-93.8%
vs FY2022
Sector context
#39 of 42
Health Care
What the data says
Among 42 Health Care companies, Twist Bioscience Corp is in the top 7% for interest expense. Interest Expense has declined for 5 consecutive years, from $1M in FY2018 to $5,000 in FY2023.
Based on SEC 10-K filings.
$5,000 in FY2023 with a 5-year CAGR of -67.2%.
Improved from $367,000 to $5,000 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -81.5%
- 5-Year CAGR
- -67.2%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 42This company $5.0K Sector average $305.3M
▼
-100.0% below sector average
Key checks
Key Insights
- Twist Bioscience Corp's interest expense has declined for 5 consecutive years.
- 5-year CAGR of -67.2%, indicating a declining trend.
- In FY2023, interest expense decreased 93.8% year-over-year.
- Ranks #39 out of 42 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $5.0K | -93.8% |
| FY2022 | $80.0K | -78.2% |
| FY2021 | $367.0K | -53.4% |
| FY2020 | $787.0K | -39.2% |
| FY2019 | $1.3M | -1.4% |
| FY2018 | $1.3M | +45.1% |
| FY2017 | $905.0K | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026